Information  X 
Enter a valid email address

Faron Pharma OY Ord NPV (DI) (FARN)

Date Time Source Announcement
19 Dec 2018 7:00 am
RNS
Traumakine update - YODA results
14 Dec 2018 11:20 am
RNS
First patient dosed in phase I/II MATINS study
11 Dec 2018 4:26 pm
RNS
Holding(s) in Company
05 Dec 2018 7:00 am
RNS
Patient subgroup identified from INTEREST trial
03 Dec 2018 7:00 am
RNS
Faron receives CTA approval for Clevegen
06 Nov 2018 3:52 pm
RNS
PDMR Dealings
23 Oct 2018 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:06 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
22 Oct 2018 3:00 pm
RNS
INTEREST trial update presented at ESICM
18 Sep 2018 9:23 am
RNS
Director/PDMR Shareholding
17 Sep 2018 7:00 am
RNS
Faron announces CTA filing for Clevegen
13 Sep 2018 7:00 am
RNS
Interim Results
12 Sep 2018 7:00 am
RNS
New data published on Clever-1 function
08 Aug 2018 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Notice of Interim Results
09 Jul 2018 8:45 am
RNS
Holding(s) in Company
28 Jun 2018 7:00 am
RNS
Clevegen successful toxicity studies
22 Jun 2018 7:00 am
RNS
Holdings in Company
  7:00 am
RNS
Holdings in Company
21 Jun 2018 3:58 pm
RNS
Director/PDMR Shareholding
  9:00 am
RNS
Price Monitoring Extension
  7:40 am
RNS
Director/PDMR Shareholding
20 Jun 2018 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  8:43 am
RNS
Holding(s) in Company
  8:43 am
RNS
Holding(s) in Company
18 Jun 2018 3:42 pm
RNS
Holdings in Company
15 Jun 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
14 Jun 2018 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Biomarker analysis of Phase III INTEREST trial
31 May 2018 2:33 pm
RNS
Result of AGM
  7:00 am
RNS
AGM Statement
16 May 2018 5:53 pm
RNS
PDMR Shareholding
15 May 2018 3:14 pm
RNS
Director/PDMR Shareholding
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  1:16 pm
RNS
Holdings in Company
11 May 2018 4:51 pm
RNS
Holding(s) in Company
  1:37 pm
RNS
Holding(s) in Company
  1:37 pm
RNS
Holding(s) in Company
  1:34 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Update on the Phase III INTEREST trial
10 May 2018 10:05 am
RNS
Notice of AGM
09 May 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  12:54 pm
RNS
Holdings in Company
08 May 2018 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Top line data from the Phase III INTEREST trial
  7:00 am
RNS
Final Results for the year ended 31 December 2017
25 Apr 2018 12:43 pm
RNS
Holdings in Company
21 Mar 2018 7:00 am
RNS
Notice of Full Year Results
06 Mar 2018 12:54 pm
RNS
Holding(s) in Company
05 Mar 2018 10:12 am
RNS
Holding(s) in Company
  10:12 am
RNS
Holding(s) in Company
 
Headlines
Top categories

21-Jan-2019 04:02 PM

Market Movers - Top risers and fallers between 15:00 and 16:00

Overall Market Futura Medical 11.35 +7.08% Clontarf Energy Ord 0.25p 0.36 +5.80% Oracle Powe ...

Company finder

a d v e r t i s e m e n t